Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27031960
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Cell+Death+Dis
2016 ; 7
(3
): e2163
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Renal cell carcinoma escapes death by p53 depletion through transglutaminase
2-chaperoned autophagy
#MMPMID27031960
Kang JH
; Lee JS
; Hong D
; Lee SH
; Kim N
; Lee WK
; Sung TW
; Gong YD
; Kim SY
Cell Death Dis
2016[Mar]; 7
(3
): e2163
PMID27031960
show ga
In renal cell carcinoma, transglutaminase 2 (TGase 2) crosslinks p53 in
autophagosomes, resulting in p53 depletion and the tumor's evasion of apoptosis.
Inhibition of TGase 2 stabilizes p53 and induces tumor cells to enter apoptosis.
This study explored the mechanism of TGase 2-dependent p53 degradation. We found
that TGase 2 competes with human double minute 2 homolog (HDM2) for binding to
p53; promotes autophagy-dependent p53 degradation in renal cell carcinoma (RCC)
cell lines under starvation; and binds to p53 and p62 simultaneously without
ubiquitin-dependent recognition of p62. The bound complex does not have
crosslinking activity. A binding assay using a series of deletion mutants of p62,
p53 and TGase 2 revealed that the PB1 (Phox and Bem1p-1) domain of p62 (residues
85-110) directly interacts with the ?-barrel domains of TGase 2 (residues
592-687), whereas the HDM2-binding domain (transactivation domain, residues
15-26) of p53 interacts with the N terminus of TGase 2 (residues 1-139). In
addition to the increase in p53 stability due to TGase 2 inhibition, the
administration of a DNA-damaging anti-cancer drug such as doxorubicin-induced
apoptosis in RCC cell lines and synergistically reduced tumor volume in a
xenograft model. Combination therapy with a TGase 2 inhibitor and a DNA-damaging
agent may represent an effective therapeutic approach for treating RCC.
|*Apoptosis/drug effects
[MESH]
|Animals
[MESH]
|Antibiotics, Antineoplastic/pharmacology/therapeutic use
[MESH]